Integra LifeSciences (IART) Stock: Buy, Sell, or Hold?

IART - Integra LifeSciences Holdings

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$16.19
-0.10 (-0.58%) â–ŧ
5d: +1.92%
30d: -2.62%
90d: -10.33%
WAIT
LOW Confidence
Protect Your IART Gains
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026 27d

Get Alerted When IART Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: IART is fairly priced but lacks strong directional signals. At 4.3% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$18.40
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$11.42
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: IART is currently trading at $16.18, which is considered fair relative to its 30-day fair value range of $15.66 to $16.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.2) compared to its historical average (5.5). At these levels, the market is pricing in 4.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.

Technical Outlook: Technically, IART is in a uptrend. Immediate support is located at $14.88, while resistance sits at $16.77.

Market Sentiment: IART scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.56 (+20.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $15.66 - $16.73
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 55.8%

Protect Your Profits

Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (31/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 20.1% below Wall St target ($19.56)
  • BEARISH: Market expects 4.3% growth - appears too optimistic based on history
  • WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $15.66 - $16.73
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$2.12 (13.1%)

Support & Resistance Levels

Support Level $14.88
Resistance Level $16.77
Current Trend Uptrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 6.24
Wall Street Target $19.56 (+20.1%)
Revenue Growth (YoY) 0.8%
Earnings Growth (YoY) 0.4%
Profit Margin -0.4%
Valuation Premium vs History +4.3% premium
PE vs Historical 6.2 vs 5.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +4.3% (market-implied from PE analysis)
1-Year Target $16.98 (+4%)
2-Year Target $17.71 (+9%)
3-Year Target $18.47 (+14%)
3-Yr Target (if PE normalizes) (PE: 6→6) PE COMPRESSION $16.28 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.4, Growth: 6.2%) $63.68 (+291%)
Base: (SPY PE: 6.2, Growth: 6.2%) $19.48 (+20%)
Bear: (PE: 5.3, Growth: 6.2%) $16.56 (+2%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 01, 2026 3:33 PM ET
Data refreshes hourly during market hours. Next update: 4:33 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IART.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$61 62 BUY
SYK
Stryker Corporation
BUY
32 analysts
$369 64 BUY
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 48 HOLD
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$120 49 HOLD
PODD
Insulet Corporation
STRONG BUY
24 analysts
$172 44 HOLD

Advanced IART Option Strategies

Professional options setups generated by AI based on today's IART price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for IART

IART Technical Chart IART Price Prediction IART Earnings Date IART Investment Advisor IART Fair Price Analyzer IART Options Advisor IART Options Chain IART Options Analysis IART Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals